Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 67 for “"HGSC"”.

  1. INVESTIGATING THE RELATIONSHIP BETWEEN THE NERVOUS SYSTEM AND HIGH-GRADE SEROUS OVARIAN CANCER

    High-grade serous ovarian cancer (HGSC) is the most lethal gynecological malignancy in the developed world. This is primarily attributable to a lack of early detection and chemoresistance in advanced disease. With this in mind, ongoing efforts in the HGSC field aim to identify components of the …

    penn Repository record for INVESTIGATING THE RELATIONSHIP BETWEEN THE NERVOUS SYSTEM AND HIGH-GRADE SEROUS OVARIAN CANCER (opens in a new tab)

  2. Investigating Novel Therapeutic Strategies in High Grade Serous Ovarian Cancer

    High Grade Serous Carcinoma (HGSC) accounts for the majority of diagnosis and deaths for patients with Ovarian Cancer (OvCa). HGSC is commonly diagnosed in the advanced stage which is associated with poor prognosis. While patients initially respond quite well to first line therapeutic interventions …

    maynooth Download PDF for Investigating Novel Therapeutic Strategies in High Grade Serous Ovarian Cancer (opens in a new tab)

  3. Effects of TGF-β Inhibitor on Chemoresistance in Ovarian Cancer Models

    High grade serous ovarian carcinoma (HGSC) is the most fatal gynecological cancer, due to the aggressive, heterogeneous nature of the tumours. Despite an initially favourable treatment response, patients with HGSC often develop resistance to the first-line platinum-based chemotherapies. In …

    queens Repository record for Effects of TGF-β Inhibitor on Chemoresistance in Ovarian Cancer Models (opens in a new tab)

  4. MOLECULAR CHARACTERIZATION OF OVARIAN CANCER PRECURSOR LESIONS

    … in the genesis of high-grade serous carcinoma (HGSC), the most common ovarian cancer, posits to its development in fallopian tubes through stepwise tumor progression. Recent progress has been made not only in gathering terabytes of omics data but also in detailing the histologic-molecular …

    jhu Repository record for MOLECULAR CHARACTERIZATION OF OVARIAN CANCER PRECURSOR LESIONS (opens in a new tab)

  5. Role of STAT1 in Disease Progression and the Tumour Immune Microenvironment of High-Grade Serous Ovarian Cancer

    Ovarian high-grade serous carcinomas (HGSC) are the most common and fatal histological subtype of ovarian cancer, characterised by late stage diagnosis and high mortality rates. Unfortunately, the majority of patients (> 85%) will develop fatal chemoresistant disease despite multiple lines of …

    queens Repository record for Role of STAT1 in Disease Progression and the Tumour Immune Microenvironment of High-Grade Serous Ovarian Cancer (opens in a new tab)

  6. Evolutionary dynamics of ovarian cancer microenvironments and tumour cells

    High-grade serous ovarian cancer (HGSC) is the most common and lethal histotype of epithelial ovarian cancer. Often presenting as multi-site disease, HGSC exhibits extensive malignant clonal diversity with widespread but non-random patterns of disease dissemination. The proclivity of HGSC toward …

    ubc Repository record for Evolutionary dynamics of ovarian cancer microenvironments and tumour cells (opens in a new tab) Download PDF for Evolutionary dynamics of ovarian cancer microenvironments and tumour cells (opens in a new tab)

  7. Potential Roles Of Circska3 In Epithelial Ovarian Cancer Development

    … be overexpressed in high-grade serous carcinoma (HGSC). Using qRT-PCR, we confirmed upregulation in HGSC tissues compared to less aggressive subtypes. Functional assays revealed circSKA3's tumor-promoting effects in HGSC cell lines, enhancing proliferation, migration, and clonogenicity. We …

    york Repository record for Potential Roles Of Circska3 In Epithelial Ovarian Cancer Development (opens in a new tab)

  8. Investigating the co-evolution of tumor antigens and the anti-tumor immune response

    Background: High-grade serous carcinoma (HGSC) can exhibit high intratumoral heterogeneity (ITH). Despite a strong association between tumor-infiltrating lymphocytes (TIL) and survival in HGSC, ITH may have profound impacts on the anti-tumor T cell response. Yet, it is unknown how anti-tumor T cell …

    uvic Repository record for Investigating the co-evolution of tumor antigens and the anti-tumor immune response (opens in a new tab)

  9. Integrated Functional and Genomic Analysis of High-Grade Serous Ovarian Cancer

    … et al., 2015). High-grade serous ovarian cancer (HGSC) is the most common and lethal subtype and the vast majority of women are diagnosed with advanced stage disease (Bowtell, 2010). The current standard treatment is aggressive surgery combined with adjuvant and/or neo-adjuvant …

    toronto-retro Repository record for Integrated Functional and Genomic Analysis of High-Grade Serous Ovarian Cancer (opens in a new tab)

  10. Μελέτη δεικτών μεθυλίωσης στον καρκίνο των ωοθηκών

    … being high grade serous ovarian carcinoma (HGSC). This doctoral thesis is focused on DNA methylation of selected genes in clinical samples of patients with HGSC. For all methylation studies, we recruited FFPE samples of primary tumors, adjacent morphologically normal tissues, as well as …

    greece Repository record for Μελέτη δεικτών μεθυλίωσης στον καρκίνο των ωοθηκών (opens in a new tab)

  11. The Investigation of the SKA3 Circular RNA Role in the Ovarian Cancer Progression

    … subtype of OC, high-grade serous carcinoma (HGSC). Our study showed that circSKA3 levels were higher in HGSC than in tumors with low malignant potential (LMP). Using functional assays, we demonstrated that overexpression of circSKA3 promoted, while the silence of cirSKA3 suppressed, …

    york Repository record for The Investigation of the SKA3 Circular RNA Role in the Ovarian Cancer Progression (opens in a new tab)

  12. Coordinated Blockade of TGF-β and PD-L1 Promotes Anti-Tumor Immunity in Ovarian Cancer Models

    High-grade serous ovarian cancer (HGSC) remains the deadliest gynecologic malignancy due to late-stage diagnosis and high recurrence rates. Current immune checkpoint blockade (ICB) therapies show limited efficacy in HGSC, with no approved immunotherapy options for patients. This is due to an …

    queens Repository record for Coordinated Blockade of TGF-β and PD-L1 Promotes Anti-Tumor Immunity in Ovarian Cancer Models (opens in a new tab)

  13. UTILIZATION OF MOUSE TUBAL EPITHELIAL ORGANOIDS TO STUDY GENE COMBINATIONS OF HIGH GRADE SEROUS OVARIAN CARCINOMA AND CELL OF ORIGIN

    … 70% will be high-grade serous ovarian carcinoma (HGSC), the most aggressive subtype. Understanding HGSC is crucial for improving patient outcomes, but research has been hindered by a lack of recurrent mutations aside from TP53 and challenges related to the homologous recombination deficiency of …

    cornell Repository record for UTILIZATION OF MOUSE TUBAL EPITHELIAL ORGANOIDS TO STUDY GENE COMBINATIONS OF HIGH GRADE SEROUS OVARIAN CARCINOMA AND CELL OF ORIGIN (opens in a new tab)

  14. The development of a blood-based test of DNA methylation for the earlier detection of high-grade serous tubo-ovarian cancer

    Background High grade serous carcinoma (HGSC) is the most common and most aggressive subtype of epithelial ovarian cancer (OC). The majority of patients present in the advanced stage with poor prognosis. If diagnosed in the earliest stage (stage I) survival is greatly improved; however, there is …

    qu-belfast Repository record for The development of a blood-based test of DNA methylation for the earlier detection of high-grade serous tubo-ovarian cancer (opens in a new tab) Download PDF for The development of a blood-based test of DNA methylation for the earlier detection of high-grade serous tubo-ovarian cancer (opens in a new tab)

  15. Deciphering and harnessing the role of tumour-infiltrating B cells in anti-tumour immunity

    … such as high-grade serous ovarian cancer (HGSC) remain resistant to immunotherapies despite harbouring TIL-Ts and TIL-Bs, suggesting that further research is needed to devise optimal immunotherapeutic strategies for these cancers. One of the most successful T cell-based immunotherapies, …

    ubc Repository record for Deciphering and harnessing the role of tumour-infiltrating B cells in anti-tumour immunity (opens in a new tab) Download PDF for Deciphering and harnessing the role of tumour-infiltrating B cells in anti-tumour immunity (opens in a new tab)

  16. Deciphering the immunosuppressive landscape of high-grade serous ovarian cancer

    High-grade serous ovarian cancer (HGSC) remains the most common and lethal subtype of ovarian cancer with a 5-year survival rate of ~30%, highlighting an urgent need for new treatments. Cancer immunotherapy has emerged as an efficacious strategy aimed at harnessing the exquisite capabilities of our …

    uvic Repository record for Deciphering the immunosuppressive landscape of high-grade serous ovarian cancer (opens in a new tab)

  17. Role of STAT1 and CXCL10 in the Tumour Immune Microenvironment of High-Grade Serous Ovarian Cancer

    High-grade serous ovarian cancer (HGSC) is the most prevalent epithelial ovarian cancer characterized by late detection, metastasis and resistance to chemotherapy. Previous studies on the tumour immune microenvironment in HGSC identified STAT1 and CXCL10 as the most differentially expressed genes …

    queens Repository record for Role of STAT1 and CXCL10 in the Tumour Immune Microenvironment of High-Grade Serous Ovarian Cancer (opens in a new tab)

  18. Repurposing Simvastatin as a Therapeutic Strategy to Treat p53 Mutant Solid Tumors

    … desperately needed. High-grade serous carcinoma (HGSC) originates in the distal fallopian tube and is the most prevalent and aggressive form of epithelial ovarian cancer. HGSC is characterized by a gain-of-function mutation in the TP53 gene, which is associated with numerous pro-tumorigenic …

    guelph Repository record for Repurposing Simvastatin as a Therapeutic Strategy to Treat p53 Mutant Solid Tumors (opens in a new tab)

  19. A Proposed Mouse Model for Spontaneous High Grade Serous Carcinoma Progression

    … treatments, high grade serous ovarian carcinoma (HGSC) remains the deadliest gynecological cancer. Currently, the molecular pathway that leads to the formation and progression of HGSC is not well known. The current paradigm for ovarian cancer development involves tumor cell transfer from the …

    ttu Repository record for A Proposed Mouse Model for Spontaneous High Grade Serous Carcinoma Progression (opens in a new tab)

  20. Recurrent transcriptomic states of plasma cell rich lymphomyeloid aggregates in high grade serous ovarian carcinoma

    … markers in high-grade serous ovarian cancer (HGSC), yet their spatial organization and niche-associated transcriptional programs remain poorly characterized. We aimed to define plasma cell rich lymphomyeloid aggregates (LMAs) - dense immune regions enriched for plasma cells - in HGSC and …

    uvic Repository record for Recurrent transcriptomic states of plasma cell rich lymphomyeloid aggregates in high grade serous ovarian carcinoma (opens in a new tab) Embargoed until 2027-04-08

Page 1 of 4